Combination Therapy with Aromatase Inhibitors in Postmenopausal Breast Cancer

in #mrmed3 months ago

Combination therapy, utilizing Aromatase Inhibitors (AIs) alongside targeted agents, has emerged as one of the promising approaches in the treatment of hormone-sensitive breast cancer in postmenopausal women. This is because endocrine or hormonal therapy was found effective in hormone-sensitive breast cancer for a considerable period of time.

Sort:  

Hello

There is reasonable evidence that this article is machine-generated.

We would appreciate it if you could avoid publishing AI-generated content (full or partial texts, art, etc.).

Thank you.

Guide: AI-Generated Content = Not Original Content

If you believe this comment is in error, please contact us in #appeals in Discord.